Clinical studies and animal experiments have demonstrated a crucial role of pro-inflammatory pathways, especially the NF-κB, IL-6/STAT3, COX-2/PGE2, and IL-23/Th17 signaling pathways, in the pathogenesis of UC CRC [11]. This evidence concerns the gene PTGS2 and colorectal carcinoma.